Cargando…

Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series

OBJECTIVE: To evaluate the efficacy and safety of half-fluence photodynamic therapy (PDT) in treating chronic central serous chorioretinopathy (CSC) in Omani population. MATERIALS AND METHODS: A Retrospective chart review of all patients with chronic CSC treated with half-fluence PDT from November 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Hinai, Ahmed S., Al-Abri, Mohammed S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160071/
https://www.ncbi.nlm.nih.gov/pubmed/21897620
http://dx.doi.org/10.4103/0974-620X.83655
_version_ 1782210517563080704
author Al-Hinai, Ahmed S.
Al-Abri, Mohammed S.
author_facet Al-Hinai, Ahmed S.
Al-Abri, Mohammed S.
author_sort Al-Hinai, Ahmed S.
collection PubMed
description OBJECTIVE: To evaluate the efficacy and safety of half-fluence photodynamic therapy (PDT) in treating chronic central serous chorioretinopathy (CSC) in Omani population. MATERIALS AND METHODS: A Retrospective chart review of all patients with chronic CSC treated with half-fluence PDT from November 2009 to December 2010 was carried out. Recorded parameters included best-corrected visual acuity, findings of clinical examination, results of fluorescein angiography and optical coherence tomography at baseline and during follow-up visits after treatment. RESULTS: Six eyes (of five Omani patients) with chronic CSC, of at least 9 months duration, were treated with half-fluence PDT. All eyes showed a complete resolution of CSC within 1 month following treatment. Four eyes showed visual improvement and two had unchanged stable vision. No complications from the treatment were noticed during the follow-up visits. CONCLUSION: Half-fluence PDT to treat chronic CSC in Omani population is a promising treatment that results in both structural and functional improvement.
format Online
Article
Text
id pubmed-3160071
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-31600712011-09-06 Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series Al-Hinai, Ahmed S. Al-Abri, Mohammed S. Oman J Ophthalmol Original Article OBJECTIVE: To evaluate the efficacy and safety of half-fluence photodynamic therapy (PDT) in treating chronic central serous chorioretinopathy (CSC) in Omani population. MATERIALS AND METHODS: A Retrospective chart review of all patients with chronic CSC treated with half-fluence PDT from November 2009 to December 2010 was carried out. Recorded parameters included best-corrected visual acuity, findings of clinical examination, results of fluorescein angiography and optical coherence tomography at baseline and during follow-up visits after treatment. RESULTS: Six eyes (of five Omani patients) with chronic CSC, of at least 9 months duration, were treated with half-fluence PDT. All eyes showed a complete resolution of CSC within 1 month following treatment. Four eyes showed visual improvement and two had unchanged stable vision. No complications from the treatment were noticed during the follow-up visits. CONCLUSION: Half-fluence PDT to treat chronic CSC in Omani population is a promising treatment that results in both structural and functional improvement. Medknow Publications 2011 /pmc/articles/PMC3160071/ /pubmed/21897620 http://dx.doi.org/10.4103/0974-620X.83655 Text en © 2011 Al-Hinai AS, et al. http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Original Article
Al-Hinai, Ahmed S.
Al-Abri, Mohammed S.
Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series
title Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series
title_full Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series
title_fullStr Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series
title_full_unstemmed Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series
title_short Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series
title_sort half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: a case series
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160071/
https://www.ncbi.nlm.nih.gov/pubmed/21897620
http://dx.doi.org/10.4103/0974-620X.83655
work_keys_str_mv AT alhinaiahmeds halffluencephotodynamictherapytotreatchroniccentralserouschorioretinopathyacaseseries
AT alabrimohammeds halffluencephotodynamictherapytotreatchroniccentralserouschorioretinopathyacaseseries